Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TET2 | Q6N021 | 3/20 | 0.46 |
| ▸ | KDM4A | O75164 | 2/20 | 0.46 |
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.46 |
| ▸ | KDM2A | Q9Y2K7 | 2/20 | 0.46 |
| ▸ | TET3 | O43151 | 1/20 | 0.46 |
| ▸ | GABRP | O00591 | 2/20 | 0.44 |
| ▸ | GABRD | O14764 | 2/20 | 0.44 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.44 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.44 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.44 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.44 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.44 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.44 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.44 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.44 |
| ▸ | GABRA4 | P48169 | 2/20 | 0.44 |
| ▸ | GABRE | P78334 | 2/20 | 0.44 |
| ▸ | GABRA6 | Q16445 | 2/20 | 0.44 |
| ▸ | GABRG1 | Q8N1C3 | 2/20 | 0.44 |
| ▸ | GABRG3 | Q99928 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL5857865 | 1.00 | TET2 (0.46) | TET2KDM4AKDM4CKDM2ATET3 | |
| SCHEMBL326464 | 0.93 | — | — | |
| SCHEMBL8655218 | 0.93 | — | — | |
| SCHEMBL23927578 | 0.93 | — | — | |
| Bicarbonate SCHEMBL9800960 | 0.90 | TET2 (0.50) | TET2KDM4AKDM4CKDM2ATET3 | |
| Water SCHEMBL6694857 | 0.90 | TET2 (0.50) | TET2KDM4AKDM4CKDM2ATET3 | |
| SCHEMBL30994572 | 0.82 | MEN1 (0.44) | TET2KDM4AKDM4CKDM2ATET3 | |
| SCHEMBL9302022 | 0.81 | TET2 (0.46) | TET2KDM4AKDM4CKDM2ATET3 | |
| SCHEMBL3056607 | 0.80 | — | — | |
| SCHEMBL30266672 | 0.80 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 191 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11918550-B2 | Sensitization of cancer cells to differentiation therapy with mitochondrial uncoupler niclosamide ethanolamine | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2024-03-05 | — | — | US | claimed |
| US-20230338322-A1 | GLYCERYLTRIACETATE (GTA) FOR USE IN IMPROVING BREATHING | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2023-10-26 | — | — | US | claimed |
| US-11684601-B2 | Treatment of cancer with combinations of agents | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2023-06-27 | — | — | US | claimed |
| EP-4146189-A1 | GLYCERYLTRIACETATE (GTA) FOR USE IN IMPROVING BREATHING | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD (IL) | 2023-03-15 | — | — | EP | claimed |
| US-20220175704-A1 | SENSITIZATION OF CANCER CELLS TO DIFFERENTIATION THERAPY WITH MITOCHONDRIAL UNCOUPLER NICLOSAMIDE ETHANOLAMINE | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | 2022-06-09 | — | — | US | claimed |
| WO-2021224912-A1 | GLYCERYLTRIACETATE (GTA) FOR USE IN IMPROVING BREATHING | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2021-11-11 | — | — | WO | claimed |
| US-10765654-B2 | Methods and compounds for treating cancer | UNIVERSITY OF VERMONT AND STATE AGRICULTURAL COLLEGE (US) | 2020-09-08 | — | — | US | claimed |
| US-20200261393-A1 | TREATMENT OF CANCER WITH COMBINATIONS OF AGENTS | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | 2020-08-20 | — | — | US | claimed |
| WO-2019180604-A1 | A SET OF DISPERSIBLE FORMULATIONS FOR TRAINING TO USE A POTTY OR A DRY BOTTOM TOILET FOR EXCRETION | SOUCKOVA DANIELA (CZ) | 2019-09-26 | — | — | WO | claimed |
| EP-1691746-B1 | MUCOADHESIVE DRUG DELIVERY DEVICES AND METHODS OF MAKING AND USING THEREOF | GEL DEL TECHNOLOGIES INC (US) | 2015-05-27 | — | — | EP | claimed |
| WO-2004100883-A2 | METHOD FOR PREPARING THERMOFORMED COMPOSITIONS CONTAINING ACRYLIC POLYMER BINDERS, PHARMACEUTUAL DOSAGE FORMS AND METHODS OF PREPARING THE SAME | BPSI HOLDINGS, INC. (US) | 2004-11-25 | — | — | WO | claimed |
| WO-2004010984-A2 | MICROCAPSULES WITH MODIFIED RELEASE OF ACTIVE PRINCIPLES WITH LOW SOLUBILITY FOR ORAL DELIVERY | FLAMEL TECHNOLOGIES (FR) | 2004-02-05 | — | — | WO | claimed |
| WO-2004010983-A2 | ORAL PHARMACEUTICAL FORMULATION IN THE FORM OF A PLURALITY OF MICROCAPSULES FOR PROLONGED RELEASE OF ACTIVE PRINCIPLE(S) WITH LOW SOLUBILITY | FLAMEL TECHNOLOGIES (FR) | 2004-02-05 | — | — | WO | claimed |
| EP-1272165-A1 | ACRYLIC ENTERIC COATING COMPOSITIONS | BPSI Holdings, Inc. (US) | 2003-01-08 | — | — | EP | claimed |
| US-6420473-B1 | ENTERIC FILM COATED POWDER | BPSI HOLDINGS, INC. | 2002-07-16 | — | — | US | claimed |
| US-20010022972-A1 | Acrylic enteric coating compositions | ROHM GMBH (DE) | 2001-09-20 | — | — | US | claimed |
| WO-2001058429-A1 | ACRYLIC ENTERIC COATING COMPOSITIONS | BPSI HOLDINGS, INC. (US) | 2001-08-16 | — | — | WO | claimed |
| US-6001341-A | Deodorant and/or antiperspirant cosmetic compositions | CONDEA AUGUSTA S.P.A. (IT) | 1999-12-14 | — | — | US | claimed |
| EP-0605694-B1 | PROCESS FOR PRODUCING CERAMIC GREEN BODIES | GAUCKLER LUDWIG J (CH) | 1996-03-27 | — | — | EP | claimed |
| US-4956404-A | POLYVINYL ACETATE BLEND WITH DEXTRIN, A GLYCEROL TRIESTER, AN EPOXIDIZED OIL, FUMED SILICA AND HYDROGENATED STARCH HYDROLYZA TES | PELZIG JOSEF (US) | 1990-09-11 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220175704-A1 | SENSITIZATION OF CANCER CELLS TO DIFFERENTIATION THERAPY WITH MITOCHONDRIAL UNCOUPLER NICLOSAMIDE ETHANOLAMINE | RARS2, NME4, ALDH2 | TET2 574/4885KDM4A 1770/4885KDM4C 2472/4885 |
| US-10765654-B2 | Methods and compounds for treating cancer | UGCG, LPCAT1, MGMT | TET2 195/4885KDM4A 267/4885KDM4C 127/4885 |
| US-20230338322-A1 | GLYCERYLTRIACETATE (GTA) FOR USE IN IMPROVING BREATHING | GDA, GMPS, GGT1 | TET2 2590/4885KDM4A 4152/4885KDM4C 4295/4885 |
| US-11918550-B2 | Sensitization of cancer cells to differentiation therapy with mitochondrial uncoupler niclosamide ethanolamine | RARS2, NME4, ALDH2 | TET2 574/4885KDM4A 1770/4885KDM4C 2472/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.